About Deep 6 AI

Who we are

Deep 6 AI (formerly Deep 6 Analytics) finds more patients for clinical trials in minutes rather than months, getting life-saving cures to people more quickly.

 

Deep 6 AI got its start by beating out some of the biggest names in analytics in a U.S. government-sponsored contest. This led to a contract with the U.S. intelligence community, which is perhaps the most complex data environment in the world. Since 2016, Deep 6 AI has focused exclusively on healthcare, participating in the Techstars Healthcare Accelerator in partnership with Cedars-Sinai, the Healthbox modified-accelerator program, and Stanford’s StartX Accelerator. Deep 6 AI was founded in 2015 and is based in Pasadena, CA.

What we do

About 90% of all data in the world is unstructured, yet very few software tools know how to leverage the information it contains. We build applications that understand massive amounts of unstructured data at a very high speed and learn from users to single out the information that is most important to them. Deep 6 AI applies artificial intelligence and natural language processing to all clinical data to find eligible patients for clinical trials faster, cutting recruitment delays significantly and getting cures to the people who need them more quickly.

Who we help

Hospitals

  • Complete trials faster and take on more research, increasing revenues
  • Improve patient outcomes and satisfaction
  • Attract and retain better physicians and researchers

Physicians

Refer patients to trials when the standard of care falls short

Patients

  • Get access to cutting-edge therapies with a single click
  • Take more control over health and treatment options

Pharma

  • Select sites based on real-time patient data
  • Accelerate recruitment for time to market and more time under patent
  • Get real-time study results

EXECUTIVE TEAM

Wout Brusselaers, CEO

WOUT BRUSSELAERS

CEO + Co-founder

Wout is the CEO and co-founder of Deep 6 AI. Wout started his career as a diplomat in the Middle East before joining global management consulting firm, McKinsey & Company, serving a wide variety of industries across Asia. Next, Wout founded an extreme sports adventure company in Singapore and then spent five years in the high-stakes world of international security, growing and leading a 22,000-headcount organization across four continents into a $500M global player. In 2015, Wout co-founded Deep 6 AI. Wout is a frequent speaker on artificial intelligence in healthcare and works closely with hospitals, pharma companies and research institutes on patient recruitment programs.

Brian Dolan, co-founder and chief scientist

BRIAN DOLAN

Chief Scientist + Co-founder

Brian is Deep 6 AI’s Chief Scientist and co-founder. Brian has led enterprise analytic projects from design to implementation for clients like EMC, SuperValu, Northern Trust, Zions National Bank, Havas Media, T-mobile, the U.S. Intelligence Community, and Research In Motion. Formerly Chief Scientist at Greenplum and Director of Research Analytics at Fox/MySpace, he has developed thousands of machine learning products. His consulting experience includes numerous state and local governments.

Andrew Hall, CTO

ANDREW HALL

Chief Technology Officer

Andrew is the CTO for Deep 6 AI. A 25-year software veteran, Andrew has a proven track record of incorporating new technology to successfully build innovative products. Formerly the Vice President of Engineering at Instant.ly and Director of Engineering for Securant Technologies, Andrew is responsible for leading the development of Deep 6 AI’s scalable application and security infrastructure.

Linda Souza, VP, Marketing

LINDA SOUZA

Vice President, Marketing

Linda has 20 years of experience in technology marketing for startups and has helped lead companies to successful acquisition, mergers, and IPOs. Previously, Linda served as VP of marketing for Central Desktop, director of marketing at Everbridge, and globalization product manager at Ariba (formerly FreeMarkets). She also heads up Chief Marketers Los Angeles.

FIND MORE PATIENTS FOR TRIALS FASTER